Rispime 1gm/0.125gm Injection
Marketer
RSM Lifecare India Private Ltd
Salt Composition
Cefepime (1gm) + Tazobactum (0.125gm)
Overview Rispime 1gm/0.125gm Injection
Rispime 1gm/0.125gm Injection combines two antibiotics to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation. Administration must be solely under a doctor's guidance; adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Typical side effects encompass nausea, vomiting, diarrhea, and skin rashes. Injection site reactions like redness, swelling, and soreness may occur but usually resolve spontaneously. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (rashes, itching, swelling, breathing difficulties) require prompt emergency care. Prior to commencing treatment, inform your physician about all current medications and pre-existing conditions. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impacting driving ability, refrain from driving if experiencing drowsiness or dizziness.
Uses of Rispime 1gm/0.125gm Injection
Infections caused by bacteria
Major Benefits of Rispime 1gm/0.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Rispime 1gm/0.125gm Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Rispime 1gm/0.125gm Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Rispime 1gm/0.125gm Injection works:
Rispime 1gm/0.125gm Injection combines Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Tazobactum counters bacterial enzymes that would otherwise neutralize Cefepime, thereby broadening its effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Rispime 1gm/0.125gm Injection and alcohol. Seek medical advice before doing so.
PregnancySAFE IF PRESCRIBED
The injectable medication Rispime (1 gm/0.125 gm) is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Rispime 1gm/0.125gm Injection is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Rispime 1gm/0.125gm Injection, temporary blurred vision may occur. Refrain from driving until vision is restored.
KidneyCAUTION
For individuals with impaired kidney function, administering Rispime 1gm/0.125gm Injection requires careful consideration. Dosage modification of Rispime 1gm/0.125gm Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Rispime 1gm/0.125gm Injection in individuals with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Rispime 1gm/0.125gm Injection :
Omit a Rispime 1gm/0.125gm Injection dose? Seek medical advice immediately.
Facts to Know About Rispime 1gm/0.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently